Medicament for treating epidural post anesthesia lumbago and backache

An epidural and pharmaceutical technology, applied in the field of anesthesiology, can solve problems such as loss of muscle support for the spine, damage to the mouth, etc., and achieve the effects of low cost, less toxic and side effects, and easy preparation.

Inactive Publication Date: 2013-03-13
王昆
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The possible reasons are aseptic inflammatory reaction of soft tissues such as ligaments and periosteum caused by local injury during puncture, repeated injury to the mouth during multiple punctures, loss of muscle support of the spine after anesthesia, and long-term maintenance of the same posture in lying position, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating epidural post anesthesia lumbago and backache

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0008] Embodiment 1: the preparation of decoction of the present invention

[0009] 15 grams of whole leaf green orchid, 20 grams of Dinggongteng, 10 grams of goldenrod, 5 grams of Jiulixiang, 10 grams of Fangfeng, 5 grams of small wild chicken tail, 5 grams of dried ginger, 10 grams of Daqingye, 5 grams of Xiaotongcao, 15 grams of Shanci mushroom gram, 20 grams of Araceae, 10 grams of Plantago, 5 grams of Kansui, 15 grams of Ishimi Chuan and 5 grams of Atractylodes macrocephala, add 1000 ml of water, place in a sealed flask, heat in a water bath at 90 °C for 3 hours, and filter , to collect the filtrate.

experiment example

[0011] 60 patients, including 23 males and 37 females, aged 23-55, mean (35.4±6.3) years old, with a course of disease ranging from 2 months to 8 years. Epidural puncture space from T 8-9 to L 3-4 Among them, 35 cases had anesthesia operation time of more than 30 minutes, and 4 cases received 2 epidural anesthesias in the same interval. The pain centered on the puncture gap, with a diameter of 5-9cm, and was mainly persistent soreness and dull pain. Divided into treatment group and control group, 30 cases in each group. All cases were routinely examined, and patients with tumors, pregnant women, abnormal coagulation function, and severe heart disease were excluded. There was no significant difference in the general data and clinical manifestations of the two groups after statistical processing (P>0.05), which were comparable.

[0012] The treatment group took the decoction prepared in Example 1 orally, twice a day, 50 milliliters each time, and treated for 4 weeks. The co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for treating epidural post anesthesia lumbago and backache. The medicament comprises the following materials in parts by weight: 10-20 parts of herba dracocephali integrifolii, 10-25 parts of erycibe obtusifolia, 1-15 parts of soldago decurrens lour, 1-10 parts of kamuning, 1-15 parts of saposhnicovia divaricata, 1-10 parts of trichomanes japonicum thunb., 1-10 parts of dried ginger, 1-15 parts of folium isatidis, 1-10 parts of medulla helwingiae, 10-20 parts of cremastra appendiculata, 10-30 parts of rhizoma arisasmatis, 1-20 parts of semen plantaginis, 1-10 parts of kansui root, 10-20 parts of salvia chinensis and 1-10 parts of bighead atractylodes rhizome. The medicament for treating epidural post anesthesia lumbago and backache has the characteristics of being low in cost, easy to prepare, less in toxic and side effects, and obvious in curative effect.

Description

technical field [0001] The invention relates to the field of anesthesiology, in particular to a medicament for treating low back pain after epidural anesthesia. Background technique [0002] Low back pain is a common complication after epidural anesthesia, with an incidence rate of 2%-31%. The possible reasons are aseptic inflammatory reaction of soft tissues such as ligaments and periosteum caused by local injury during puncture, repeated injury to the mouth during multiple punctures, loss of muscle support of the spine after anesthesia, and prolonged lying in the same posture. Therefore, there is an urgent need to find a medicament for the treatment of low back pain after epidural anesthesia. Contents of the invention [0003] The object of the present invention is to provide a medicament for treating low back pain after epidural anesthesia. [0004] In order to realize the object of the present invention, the present invention provides a kind of medicament for the tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P29/00
Inventor 王昆
Owner 王昆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap